European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

LifeGlimmer GmbH, Berlin, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

LifeGlimmer GmbH

Register

Ut
District Court of Charlottenburg (Berlin) HRB 141983 B

Address

Markelstr. 38, 12163 Berlin, Germany

Corporate purpose

Analysis of genomic data, generation and analysis of virtual organisms, analysis of clinical data, and model calculations for product optimization.

Financials

Revenue

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Publications

1 Jan 2023 in Fts
EU funding (€231,704): 101094287 - Bioindustry 4.0 - RI Services to Promote Deep Digitalization of Industrial Biotechnology - Towards Smart Biomanufacturing
1 Oct 2022 in Fts
EU funding (€47,482): 101070281 - Bios - Bios: the BIO-Intelligent Dbtl Cycle, a KEY Enabler Catalysing the Industrial Transformation Towards Sustainable Biomanufacturing
1 Oct 2022 in Fts
EU funding (€727,748): 101070281 - Bios - Bios: the BIO-Intelligent Dbtl Cycle, a KEY Enabler Catalysing the Industrial Transformation Towards Sustainable Biomanufacturing
1 Oct 2022 in Fts
EU funding (€20,448): 101070281 - Bios - Bios: the BIO-Intelligent Dbtl Cycle, a KEY Enabler Catalysing the Industrial Transformation Towards Sustainable Biomanufacturing
25 Mar 2022
Original document: “Liste der Gesellschafter“
1 Jan 2020 in Fts
EU funding (€3,851.70): 874703 - Ephor - Exposome Project for Health and Occupational Research
1 Jan 2020 in Fts
EU funding (€149,983): 874703 - Ephor - Exposome Project for Health and Occupational Research
1 Jan 2020 in Hor
EU funding (€152,746): Exposome project for health and occupational research
2 Sept 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
1 Sept 2019 in Fts
EU funding (€240,148): 860895 - Transys - Translational Systemics: Personalised Medicine AT the Interface of Translational Research and Systems Medicine
1 Sept 2019 in Fts
EU funding (€12,639.35): 860895 - Transys - Translational Systemics: Personalised Medicine AT the Interface of Translational Research and Systems Medicine
28 Aug 2019 in Hor
EU funding (€252,788): Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine
1 May 2019 in Fk
Public funding (€250,612): PERMIT - Personalized Medicine for Infectious Diseases: From System Biomedicine and Immunometabolism to Precision Diagnostics and Sttratification
1 Oct 2018 in Fts
EU funding (€244,797): 812968 - Perico - Peroxisome Interactions and Communication
1 Oct 2018 via Biofaction KG
EU funding (€252,788): Peroxisome Interactions and Communication
1 Dec 2017 in Fts
EU funding (€32,393): 730976 - Ibisba 1.0 - Industrial Biotechnology Innovation and Synthetic Biology Accelerator
1 Dec 2017 in Hor
EU funding (€34,160): Industrial Biotechnology Innovation and Synthetic Biology Accelerator
26 Apr 2016
Managing Director: Vitor A. dos Santos
3 Mar 2016
No longer Managing Director: Susanne Hollmann
1 May 2015 in Fts
EU funding (€533,319): 635536 - Empowerputida - Exploiting Native Endowments by RE-Factoring, RE-Programming and Implementing Novel Control Loops in Pseudomonas Putida for Bespoke Biocatalysis
1 May 2015 in Hor
EU funding (€581,750): Exploiting native endowments by re-factoring, re-programming and implementing novel control loops in Pseudomonas putida for bespoke biocatalysis
4 Nov 2014
Managing Director: Susanne Hollmann · No longer Managing Director: Babette Regierer
1 Sept 2014 in Fk
Public funding (€18,407.00): Standardization and standardization for the exchange of models and data in system biology research (NORM-SYS), sub-projects Company-relevant aspects of standardization in …
11 Feb 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
19 Nov 2013
Address
7 Mar 2013
Managing Director: Babette Regierer · No longer Managing Director: Susanne Hollmann
1 Jan 2013 in Fts
EU funding (€610,354): Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures That Dictate Severity of Tissue Infection
1 Jan 2013 in Fts
EU funding (€136,944): Peroxisomes: KEY to Cell Performance and Health
1 Dec 2012 in Fts
EU funding (€477,150): Systems Medicine of Chronic Inflammatory Bowel Disease
1 Sept 2012 in Fts
EU funding (€856,625): Sustainable PoLymers From Algae Sugars and Hydrocarbons
23 May 2012
Reg­is­tra­tion · MD: Susanne Hollmann · Address · Capital: €25,000 · Share­holder agreement · Seat: Berlin, Germany · Legal form: GmbH · Name: LifeGlimmer GmbH · Proxy · Corporate Purpose

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "LifeGlimmer GmbH, Berlin, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close